We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Adaptimmune Announces Opening of Phase I/II Clinical Trial in Multiple Myeloma

News   May 27, 2011

 
Adaptimmune Announces Opening of Phase I/II Clinical Trial in Multiple Myeloma
 
 
Advertisement
 

RELATED ARTICLES

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Lab Profiles That Differentiate MIS-C From COVID-19 in Children Identified

News

Researchers from Children’s Hospital of Philadelphia report important data that differentiate MIS-C from severe COVID-19 in children and suggest that MIS-C is a post-infectious syndrome related to COVID-19 but distinct from KD.

READ MORE

Test Rapidly Determines Amount of SARS-CoV-2 Neutralizing Antibodies

News

A Swiss-German team has developed a test that determines the amount of SARS-CoV-2 neutralizing antibodies within a short period of time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE